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Introduction
Clinically, non-selective muscarinic receptor agonists such as pilocarpine are used to rapidly lower intraocular pressure (IOP) by increasing conventional outflow facility [1] [2] [3] . Pilocarpine increases conventional outflow by binding to and activating muscarinic M3 receptors on ciliary smooth muscle cells, stimulating contraction 4 . The ciliary muscle in primates is compound, having circular and longitudinal fibers. Anchored to the choroid, longitudinal ciliary muscle contraction pulls on tendons that extend into the conventional outflow tract, terminating in the trabecular meshwork and inner wall of Schlemm's canal (SC) 5, 6 . Functional consequences of ciliary muscle contraction appear to include expansion of the juxtacanalicular portion of the trabecular meshwork and opening of the lumen of SC. Ciliary muscle tone is critical for proper functioning of the conventional outflow tract because at elevated IOP the lumen of SC is prone to collapse 7, 8 . Hence, in addition to the presence of septae (struts) that span from the inner to outer wall to prop the SC lumen open near collector channels, tension from the ciliary muscle helps keep open SC in between collector channels; maintaining flow of aqueous humor into the canal and return to the systemic circulation.
In addition to outflow effects, pilocarpine-stimulated ciliary muscle contraction in primates results in the inward and anterior movement of the circular ciliary muscle fibers 9 . Displacement of ciliary muscle mass releases tension on the zonules of the crystalline lens, thereby enabling accommodation as the lens rounds up. In parallel, pilocarpine interacts with muscarinic receptors in the iris sphincter muscle cells to constrict the pupil. Due to availability of drugs without these two later effects (accommodation and miosis), pilocarpine is not generally used as a first line treatment of ocular hypertension. However, due to its rapid, efficacious and transient effects, pilocarpine is often used for a variety of ocular applications including the acute treatment of ocular hypertension in clinical emergencies.
Interestingly, mice do not accommodate, but have a ciliary muscle; suggesting that a primary purpose of the ciliary muscle in mice (and possibly humans) is for the regulation of outflow facility 10 . Similar to human, mouse eyes have two layers of longitudinal ciliary muscle fibers that converge onto "tips", which pull on tendons that extend into the trabecular meshwork and inner wall of SC 10 . Unlike other non-accommodating species like porcine and bovine, mice have a conventional outflow tract that is anatomically, physiologically and pharmacologically very similar to human 11, 12 . While some anatomical features are not identical between human and mice (discontinuous scleral spur and anterior versus posterior fixation of TM), treatment of mouse eyes with pilocarpine lowers IOP 13, 14 , and perfusion of enucleated mouse eyes with pilocarpine results in increased outflow facility 10 ; consistent with its role in modulating conventional outflow function like human. Effects of pilocarpine in mouse and primate eyes is in contrast to pilocarpine effects in bovine eyes, which does the opposite and decreases outflow facility 15, 16 . Taken together, these data are consistent with anatomical and pharmacological differences between eyes with angular aqueous plexus, like bovine or porcine, and eyes with SC, like rodents and primates.
While the effects of pilocarpine on ciliary muscle contraction and lens rounding have been documented in living monkeys by optical coherence tomography (OCT) 9 , effects of pilocarpine on conventional outflow tissues were not resolved. Due to their relatively thin sclera and large SC lumen, the conventional outflow pathway of mice is a good candidate for in vivo microscopic imaging. Several recent studies have address the problem of imaging SC in human eyes [17] [18] [19] [20] , However, documentation of SC behavior of mice with OCT has different technical obstacles than human (i.e. small eye, blood in canal, and need for iridotomy to prevent anterior chamber deepening). Recent improvements in the resolution of commercial OCT systems, customized for murine eye imaging, now enable direct visualization of conventional outflow behavior in living mice. Using a custom built mouse housing platform for a commercial spectral domain (SD)
OCT system, the goal of the present study was twofold: (i) to explore and optimize techniques to image the conventional outflow pathway of mice in vivo using SD-OCT and (ii) to examine the effects of elevated IOP on SC lumen collapse in the presence and absence of pilocarpine in living mice. To be complete, we also examined the effects of pilocarpine on intraocular pressure and conventional outflow facility in living mice.
Methods

Animals
Mice were handled in accordance with animal care and use guidelines of Duke University and in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research. CD1 mice were purchased from the Jackson Laboratory (Bar Harbor, Maine, USA), bred/housed in clear cages and kept in rooms at 21°C with a 12 h: 12 h light-dark cycle. Mice were used at ages between 4 to 8 weeks old. Due to the potential effect of posterior iris bowing and anterior chamber deepening 21 , we performed iridotomies to equalize pressure on both sides of iris. Iridotomy was conducted on the left eye of all mice one to two weeks before OCT imaging: Briefly, mice were anesthetized by intraperitoneal injection of Ketamine (100mg/kg) and Xylazine (10mg/kg). A drop of Proparacaine, a topical anesthetic, was applied to the left eye. A clear-corneal wound was made with a Beaver 75 blade under an operating microscope.
A 0.12 forceps was used to grasp the iris and a small iridotomy hole (~2 mm) was cut using Vannes scissors. Erythromycin, a topical antibiotic ointment was applied to the cornea, and the animals were maintained on a warm water-circulating blanket until recovery from the anesthesia.
OCT Imaging
In vivo imaging was performed utilizing an Envisu R2200 Ultra-high-resolution SD-OCT system (Bioptigen Inc., Research Triangle Park, NC). This 840 nm SD-OCT system utilized customized 180 nm Superlum Broadlighter source providing two micron axial resolution, and a 12mm telecentric lens bore for anterior segment OCT imaging.
For OCT experiments, mice were anesthetized as described for iridotomy, then placed on a custom-made OCT imaging mount that we designed and manufactured specifically for imaging mice ( Figure 1 ). This imaging mount was equipped with an onboard micromanipulator to insert a glass cannula into the temporal quadrant of the anterior chamber to control and measure IOP.
Moreover, the imaging mount fit perfectly into the Bioptigen OCT alignment stage to accurately position and hold the OCT probe for imaging sessions.
A pulled glass micro-needle was filled with phosphate buffered saline (PBS) and inserted into the mouse anterior chamber. The micro-needle was connected to both a manometric column to adjust IOP and a pressure transducer to continuously monitor IOP levels (using PowerLab software). The OCT probe was aimed at the inferior lateral limbus and the image was centered and focused at SC. While collecting images at the same region of SC, the mouse eye was subjected to a series of IOP steps (10, 12, 15, 17, 20, 22, 25, 35, . Each averaged OCT image was opened into ImageJ software (freeware; National Institutes of Health, Bethesda, MA) and SC area was marked and area calculated. Estimates of lumen borders were verified with the lumen edges observed in live video; comparing stationary lumen edges with moving reflectors (blood cells in lumen). Area calculations at each pressure level were normalized to untreated 10 mmHg control group. All images were analyzed on two separate occasions (over two months apart) by the same trained observer (GL) to assess intraobserver variability. Intra-observer reliability was calculated by comparing the average difference between normalized SC lumen area measurements at the two sessions (over the entire range of IOPs)
For pilocarpine experiments, untreated eyes were imaged sequentially at each pressure step, and then the IOP was set back to 10 mmHg for 10 min. A drop of 1% pilocarpine was then given to the mouse eye, and kept for another 10 min. The eyes were then subjected to the same pressure sequence as before, and images were captured at each pressure level.
OCT Image Post-Processing
High signal-to-noise-ratio images of the anterior segment were generated at each IOP step by registering and averaging each sequence of repeated OCT B-scans. Rigid body image registration was performed using the ImageJ (freeware; National Institutes of Health, Bethesda, MA) StackReg registration plug-in 18 .
To visualize regions with fluid flow (e.g. blood vessels and SC), we generated speckle variance Due to the high-resolution imaging capabilities of our OCT system and the prone position of the animals, which roughly aligned the eye and heart along the same horizontal plane, we were able to visualize red cells inside the SC lumen as a result of venous congestion. While the presence of red cells facilitated visualization of the SC lumen (and surrounding vessels), it also introduced some blurring to the averaged images. These artifacts were reduced by locally enhancing the image using adaptive histogram equalization 26 , where the regions of interest were isolated through thresholding of the speckle variance image.
Histology
Mice with iridotomized eyes were anesthetized systemically by intraperitoneal injection of Ketamine (100mg/kg) and Xylazine (10mg/kg) and then 10 μl of 1% pilocarpine eye drop was applied to one eye. Twenty minutes later, two glass micro-needles connected to a fluid reservoir filled with fixative solution (2.5% paraformaldehyde, 0.75% glutaraldehyde) were inserted into anterior chamber of each eye. Both eyes were perfused simultaneously at IOPs 10, 25, or 45 mmHg for 1h. After perfusion, mice were euthanized and the eyes were collected and immersed into fixative solution overnight at 4˚C. The eyes were bisected, posterior segments and lens were removed. The anterior segments were cut into four quadrants and each quadrant was embedded into Epon. Blocks were cut into 0.5 µm semi-thin sections and stained with 1% methylene Blue. The images were captured digitally using light microscopy.
Outflow facility
Outflow facility measurements were conducted in living mouse eyes as previously described 27 .
Briefly, for bilateral measurements two micropipette manipulators were used to place a microneedle in each mouse eye. Each microneedle was connected to a pressure tubing (0.05 inch inner diameter (Mallinckrodt, Hazelwood, Missouri, USA) leading to a three-way stopcock.
The stopcock was connected to a 5-mL syringe filled with PBS and to pressure tubing to the decline in height of the column over time, and thereby was used to determine the flow rate based on the dimensions of the fluid column. The average pressure over 10 minutes was used due to slight decline in pressure over time. Outflow facility data were excluded if the mouse died or leaking occurred during outflow facility measurements. Flow was measured at three different pressures (~17, 24 and 34 mmHg), a linear regression analysis was performed and slopes of pressure-flow relationships were compared between control and pilocarpine (topically treated) eyes to determine outflow facility.
Intraocular Pressure
IOP was measured in iridotomized eyes following 1% pilocarpine treatment in living mouse eyes using rebound tonometry (TonoLab). Briefly, mice were lightly anesthetized with Ketamine (50mg/kg) and Xylazine (5mg/kg) to limit IOP effects and watched for time when they just stopped moving (light sleep). IOP was immediately measured. Each IOP level was the average of six measurements from the same eye. After collection of IOPs from untreated eyes, 10 μl of 1% pilocarpine eye drop was given and IOP was measured at 20, 40, 120 and 210 min after treatment. Liquid around the eyes was removed using a Kimwipe before each series of IOP measurements. All mice were lightly anesthetized during IOP measurements, except at the 210 min time point when mice were just awakening from anesthesia.
Statistical analysis
Statistical significance between groups was assessed by either the Mann-Whitney U-test for comparing data from different eyes or paired student t-tests for comparing data from same mouse eyes. A value of p<0.05 was considered statistically significant.
Results
The OCT probe was pointed toward the inferior lateral limbus region of mouse eyes in vivo, focusing on the iridio-corneo angle at an open SC lumen, appearing similar to observed previously by standard histology (Supplemental Figure 1) . A comparison of the three types of OCT images that are provided in figure 2 to view behavior of SC, averaged intensity, contrast enhanced and speckle variance. Inside blood vessel lumens, including SC we saw "speckling", presumably caused by red cells during live imaging. Speckling caused some blurring in SC or vessels in processed images after averaging, but made SC lumen walls easily identifiable as seen using information from both enhanced and speckle variance images. In speckle variance images, speckling features from above cast a shadow on structures below, making lower boundaries ambiguous.
Behavior of SC in response to IOP
Once imaging techniques with mice were optimized, we then monitored SC and TM behavior in Although we were unable to detect changes in the TM, at 20 mmHg the SC canal lumen is almost entirely collapsed. However, we often observed the distal ends of the canal partially open. Moreover, we noticed that SC in these young mice fully collapses around 35 mmHg, but readily reopens to their initial dimensions upon returning IOP to 10 mmHg. Shown in figure 4 is combined analysis of SC lumen area taken from different mice exposed to sequential pressure gradients and normalized to initial dimensions at 10 mmHg. To quantify area of SC, lumen was marked (as in Figure 2 ) and the area was calculated on averaged intensity images using ImageJ. Edges of lumen for each condition were verified using live video of experiment, comparing stationary lumen edges with moving reflectors in lumen. Intra-observer variability was low and reliability of measurements was high, having only a 13.8±11.5% difference in two measurements of each image on two separate occasions by a single trained observer (GL).
Effects of pilocarpine on mouse outflow pathway
Using pilocarpine, we tested the idea that ciliary muscle contraction opposes SC collapse experimentally in living mice. Using the same mouse eyes that were subjected to the first set of pressure steps without treatment; we retested response of SC after the application of 1%
pilocarpine. Upper right panel in figure 3 shows that pilocarpine rapidly widened SC (within 10 min) in eyes held at the 10 mmHg level by 131.6±21% compared to pre-treatment levels.
Concomitantly, the anterior lamellated trabecular meshwork was pulled inward and expanded into an open fan-like shape that widened approaching the anterior chamber (arrows in figure 3 ).
In contrast, the angle between the cornea and iris (36. 
SC lumen area in response to IOP gradients and pilocarpine using standard histology
Similar to results obtained in living mice with OCT, histology results in figure 6 show that SC lumen area in pilocarpine-treated eyes was larger than control, whether fixed by immersion at spontaneous IOP or perfusion fixation at 10 mmHg. Moreover, we observed that SC lumen was larger in pilocarpine-treated eyes at each of three pressure steps tested (10, 25 and 45 mmHg).
Pilocarpine appeared to prevent complete SC collapse that was observed at 45 mmHg in untreated control eyes. Fixation seemed not to alter to the lumen of Schlemm's canal. However, the appearance of the trabecular meshwork depended upon fixation conditions, and presumably on the location of the lens and iris that cannot be reliably kept in place during histological sectioning.
Pilocarpine effects on outflow facility and IOP in living mice
To relate changes in SC lumen area observed by OCT with traditional functional measures, we examined effects of pilocarpine on conventional outflow facility and IOP in two cohorts of living mice. Figure 7 shows the pressure-flow relationship of paired mouse eyes, one treated topically with PBS and the contralateral eye treated topically with 1% pilocarpine. The anterior chamber of eyes were cannulated and subjected to three pressure steps ( and mice in these studies may be attributable to differences in the ciliary muscle tone or anatomical differences, such as the relative absence a scleral spur, that predisposes SC to collapse a lower IOPs in mice. Moreover, because the majority of past studies relied on histology, it was not possible for previous investigators to examine the reversibility of SC collapse within individual eyes. In contrast, because we were imaging living animals noninvasively, we were able to look at multiple pressure steps in a single animal and revert back to initial pressure and examine recovery in real time. The rapid recovery of SC lumen dimensions (within minutes) emphasizes the importance of the elastic network in the conventional tract in mice and humans 10, 29 . It would be interesting in the future to see if there are differences in recovery from IOP challenges in young versus old mice.
As with previous studies, standard histology provided a good representation of snapshots of conventional outflow behavior at a specific IOP in the presence or absence of pilocarpine.
Compared with OCT images, the general appearance of the SC lumen was dimensionally similar; however eyes were perfusion-fixed at a single IOP, so we could not obviously follow changes in SC lumen or flow within the SC lumen (speckle variance) over a range a pressures.
It was interesting that we did not see a marked difference in appearance of SC lumen between perfusion and immersion fixed eyes treated with pilocarpine, suggesting that ciliary muscle contraction maintains SC dimensions during fixation. However, it was difficult to measure changes in the width of the trabecular meshwork in response to pilocarpine in histological sections on account of the lens and iris that are difficult to keep in place.
The mouse eye continues to prove a valuable model for studying human conventional outflow.
Even though it does not accommodate, the mouse (like human) has a ciliary muscle that is connected via tendons to an elastic network in the trabecular meshwork that extends onto the inner wall of SC. Like previous studies in living mice 14 , we observed a 3-7 mmHg drop in IOP following pilocarpine treatment. Effects are likely due to decreased inflow 30 and increased in outflow. The role of the ciliary muscle to modify conventional outflow function in mice was tested in situ, and contraction resulted in a doubling of outflow 10 . In the present study, we extended these finding to living mice, and found that ciliary muscle contraction increased conventional outflow 4-fold. The disparity in these magnitudes are unclear, but are likely due to differences in techniques used to measure facility and/or uncontrolled variables in living animal (i.e.: autonomic tone, blood supply, etc.). Regardless, the important point is that pilocarpine increases outflow, like human, and emphasizes the usefulness of mouse to study conventional outflow function. By OCT imaging, the increase in outflow facility in living mice appears to be caused by an expansion of SC lumen and widening of the TM, likely due to traction from the ciliary muscle contraction. Importantly, pilocarpine prevented SC collapse at susceptible IOPs.
Thus, it appears that a primary role of the ciliary muscle is to keep open the conventional outflow tract and prevent SC collapse.
The source of the "speckling" in SC and neighboring blood vessels is unknown, but is likely . These data provide additional evidence for functional similarities between human and mice in terms of aqueous humor dynamics.
With improved resolution and custom built mouse mounting stages (e.g. Figure 1 ), OCT technology now represents a valuable tool for learning about the normal physiology, pharmacology and pathology of the conventional outflow tract 17, 18, 19 . For example, questions about alterations in outflow tissue behavior with age, or with disease in recently established disease models in rodents for ocular hypertension [32] [33] [34] [35] can now be specifically addressed.
Since glaucoma is a group of diseases many of which impact conventional outflow function, it will be interesting to see if OCT can discriminate between these models with different genetic etiologies. Moreover, as new classes of drugs that target the conventional outflow pathway move through the drug company pipeline and are soon used by patients, the need to monitor drug efficacy becomes a reality. The present study clearly showed that effects of a currently prescribed drug, pilocarpine, on conventional outflow tissue behavior can be resolved by OCT. , technological obstacles currently exist to prevent clinical utility of SD-
OCT. The present study demonstrates the power of SD-OCT imaging of conventional outflow behavior in mice, where many issues can be worked out for future use in human. 
